Mo Xinyi相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Exploring the optimal regimen in advanced hepatocellular carcinoma: a protocol of individual patient data network meta-analysis of randomized controlled trials

探索晚期肝细胞癌的最佳治疗方案：一项基于个体患者数据网络的随机对照试验荟萃分析方案

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2026.1804661

Luo, Jiefeng; Li, Zhengxiong; Ge, Jun; Cai, Sizhen; Mo, Xinyi; Liu, Wensheng; Gui, Chengxia; Du, Qiong

细胞生物学

发表日期：2026

文献求助收藏

Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma: A cost-effectiveness analysis

纳武利尤单抗联合伊匹木单抗对比乐伐替尼或索拉非尼作为不可切除肝细胞癌一线治疗方案的成本效益分析

影响因子:5.1

doi:10.1002/cncr.70259

Luo, Jiefeng; Li, Zhengxiong; Ge, Jun; Cai, Sizhen; Mo, Xinyi; Liu, Wensheng; Gui, Chengxia; Du, Qiong; Liu, Jiyong

细胞生物学

发表日期：2026

文献求助收藏

Transcriptomic and Widely Targeted Metabolomic Approach Identified Diverse Group of Bioactive Compounds, Antiradical Activities, and Their Associated Genes in Six Sugarcane Varieties.

转录组学和广泛靶向代谢组学方法鉴定了六种甘蔗品种中的多种生物活性化合物、抗自由基活性及其相关基因

期刊:Antioxidants

影响因子:6.6

doi:10.3390/antiox11071319

Rao Muhammad Junaid, Duan Mingzheng, Wang Jihong, Han Shijian, Ma Li, Mo Xinyi, Li Min, Hu Lihua, Wang Lingqiang

发表日期：2022

文献求助收藏

The Novel LncRNA AK035396 Drives Cardiomyocyte Apoptosis Through Mterf1 in Myocardial Ischemia/Reperfusion Injury

新型 LncRNA AK035396 通过 Mterf1 驱动心肌缺血/再灌注损伤中的心肌细胞凋亡

期刊:Frontiers in Cell and Developmental Biology

影响因子:4.6

doi:10.3389/fcell.2021.773381

Zhaoyan Xu, Yuanxi Mo, Xinyi Li, Wanzi Hong, Sisi Shao, Yaoxin Liu, Fen Shu, Lei Jiang, Ning Tan

细胞生物学

发表日期：2021

文献求助收藏